Αρχική World News EMA Recommends a Change to the Terms of the Marketing Authorisation for... World News EMA Recommends a Change to the Terms of the Marketing Authorisation for Mosunetuzumab Από Ogkologos - 23 Οκτωβρίου, 2025 437 0 Facebook Twitter Google+ Pinterest WhatsApp It adopted a new route for administration along with a new pharmaceutical form Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Living With Metastatic Breast Cancer: How I Reinvented Myself 30 Οκτωβρίου, 2020 How Do Black People with Cancer View Clinical Research? 15 Νοεμβρίου, 2024 Prognostic Role of ctDNA in Patients with Surgically Resectable Colorectal Cancer 30 Ιανουαρίου, 2023 Empowering People With Cancer: A Q&A With Cancer.Net Editor in Chief... 8 Ιουνίου, 2021 Φόρτωση περισσοτέρων HOT NEWS Belzutifan Plus Lenvatinib Improves Outcomes Over Cabozantinib in Patients with Advanced... Breast cancer surgery: ‘I’m proud of the tattoos inked across my... Grace and Love for Full Hands Tackling under-representation of Black data scientists in cancer research